0001415889-23-007888.txt : 20230512 0001415889-23-007888.hdr.sgml : 20230512 20230512160804 ACCESSION NUMBER: 0001415889-23-007888 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230511 FILED AS OF DATE: 20230512 DATE AS OF CHANGE: 20230512 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Jacobson Allan Steven CENTRAL INDEX KEY: 0001579003 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35969 FILM NUMBER: 23915700 MAIL ADDRESS: STREET 1: PTC THERAPEUTICS, INC. STREET 2: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PTC THERAPEUTICS, INC. CENTRAL INDEX KEY: 0001070081 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 043416587 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 BUSINESS PHONE: 9082227000 MAIL ADDRESS: STREET 1: 100 CORPORATE COURT CITY: SOUTH PLAINFIELD STATE: NJ ZIP: 07080-2449 FORMER COMPANY: FORMER CONFORMED NAME: PTC THERAPEUTICS INC DATE OF NAME CHANGE: 19980909 4 1 form4-05122023_080552.xml X0407 4 2023-05-11 0001070081 PTC THERAPEUTICS, INC. PTCT 0001579003 Jacobson Allan Steven C/O PTC THERAPEUTICS, INC. 100 CORPORATE COURT SOUTH PLAINFIELD NJ 07080 true false false false 1 Common Stock 2023-05-11 4 M 0 23000 10.85 A 35348 D Common Stock 2023-05-11 4 S 0 19040 54.7833 D 16308 D Common Stock 2023-05-11 4 S 0 2860 56.3528 D 13448 D Common Stock 2023-05-11 4 S 0 1100 56.9881 D 12348 D Stock Option (Right to Buy) 10.85 2023-05-11 4 M 0 23000 10.85 D 2023-05-15 Common Stock 23000 0 D Stock Option (Right to Buy) 27.05 2024-01-27 Common Stock 10000 10000 D Stock Option (Right to Buy) 51 2025-01-01 Common Stock 12000 12000 D Stock Option (Right to Buy) 30.86 2026-01-03 Common Stock 12000 12000 D Stock Option (Right to Buy) 11.23 2027-01-02 Common Stock 12000 12000 D Stock Option (Right to Buy) 18.01 2028-01-02 Common Stock 14000 14000 D Stock Option (Right to Buy) 33.02 2029-01-21 Common Stock 14000 14000 D Stock Option (Right to Buy) 51.16 2030-01-28 Common Stock 10000 10000 D Stock Option (Right to Buy) 66.49 2031-01-05 Common Stock 10000 10000 D Stock Option (Right to Buy) 38.10 2032-01-06 Common Stock 12000 12000 D Stock Option (Right to Buy) 39.42 2033-01-04 Common Stock 10000 10000 D This transaction was effected pursuant to a written Rule 10b5-1 plan adopted by the Reporting Person on November 11, 2022. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $54.45 to $55.35 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $55.84 to $56.81 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. This price represents the weighted average price of sale transactions that were executed in multiple trades at prices ranging from $56.85 to $57.15 per share. The Reporting Person hereby undertakes, upon request by the SEC staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price. Currently exercisable. This option was granted on January 5, 2023 and vests over one year in twelve equal monthly installments, commencing on February 5, 2023. /s/ Avraham S. Adler, Attorney-in-Fact 2023-05-12